Table 2.
Characteristics of Hypertensive Patients
| Characteristic | Total (N=48) |
|---|---|
| Age, y | 76.4±7.8 |
| Male:female ratio | 20:28 |
| Body mass index, kg/m2 | 24.7±4.2 |
| Regular drinkers, % | 18.8 |
| Current smokers, % | 2.1 |
| Dyslipidemia, % | 55.7 |
| Diabetes mellitus, % | 22.2 |
| eGFR, mL/min/1.73 m2 | 66.4±13.2 |
| Hyperuricemia, % | 6.2 |
| History of cardiovascular disease, % | 6.8 |
| Antihypertensive medications | |
| No. of antihypertensive drugs | 2.0±1.0 |
| CCB, % | 78.2 |
| ACE inhibitor, % | 2.6 |
| ARB, % | 73.9 |
| β blocker, % | 6.6 |
| α blocker, % | 8.6 |
| Diuretic, % | 19.6 |
| Timing of antihypertensive medications | |
| After breakfast, % | 79.2 |
| After dinner, % | 29.2 |
| Time of daily schedules | |
| Wake‐up, h:min | 6:14±00:39 |
| BP measurement in the morning, h:min | 6:40±01:00 |
| BP measurement before dinner, h:min | 17:34±01:07 |
| Bathing, h:min | 19:56±01:43 |
| BP measurement at bedtime, h:min | 21:06±01:32 |
| Bedtime, h:min | 21:40±01:29 |
Values are the expressed as mean±standard deviation or number (percentage). Abbreviations: ACE, angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; BP, blood pressure; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate.